Finance

Lists
Why is HIMS down 2,85%?
Dive Deeper
HIMS:NYSE
Hims & Hers Health Inc
17,05 $
-2,85%
(-0,50) 1D
17,20 $
+0,88% (+0,15)
After hours
Closed: 18 նոյ, 16:00:03 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HIMS...
Open
17,88 $
High
18,20 $
Low
17,02 $
Mkt. cap
4,00 մլրդ
Avg. vol.
14,07 մլն
Volume
9,59 մլն
52-wk high
40,99 $
52-wk low
13,74 $
EPS
-0,83 $
Beta
2,53
Shares outstanding
226,04 մլն
No. of employees
2 հզր
Open
17,88 $
High
18,20 $
Low
17,02 $
Mkt. cap
4,00 մլրդ
Avg. vol.
14,07 մլն
Volume
9,59 մլն
52-wk high
40,99 $
52-wk low
13,74 $
EPS
-0,83 $
Beta
2,53
Shares outstanding
226,04 մլն
No. of employees
2 հզր
News stories
From web sources and news partners
Profile
Hims & Hers Health, Inc., doing business as hims, is an American telehealth company headquartered in San Francisco. It provides prescription medications, over-the-counter medications, and personal care products through a direct-to-consumer subscription model. Wikipedia
About Hims & Hers Health Inc
CEO-
Employees2,44 հզր
Foundedնոյ 2017
HeadquartersՍան Ֆրանցիսկո, Կալիֆոռնիա, Միացյալ Նահանգներ
SectorHealth Care
IndustryHealth care provider
Website-
Analyst ratings
Based on 12 analysts giving stock ratings to HIMS in the past 3 months
Hold
Buy
3
Hold
9
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for HIMS in the last 3 months.
Highest
Current 17,05 $
40,00 $ (+134,60%)
Average
29,22 $ (+71,38%)
Lowest
24,00 $ (+40,76%)
Analyst
Recommendation
Action
Price target
Projected
Date
Justin Patterson
KeyBanc
Hold
Maintained
-
-
11/11/2026
Allen Lutz
Bank of America Securities
Hold
Maintained
-
-
11/10/2026
Michael Cherny
Leerink Partners
Hold
Maintained
24,00 $
+40,8%
11/10/2026
Bryan Smilek
J.P. Morgan
Hold
Maintained
24,00 $
+40,8%
11/10/2026
Mark Mahaney
Evercore ISI
Hold
Maintained
27,00 $
+58,4%
11/10/2026
Brian Tanquilut
Jefferies
Hold
Maintained
24,00 $
+40,8%
11/10/2026
Craig Hettenbach
Morgan Stanley
Hold
Reiterated
25,00 $
+46,6%
11/10/2026
Ryan MacDonald
Needham
Buy
Reiterated
32,00 $
+87,7%
11/10/2026
Maria Ripps
Canaccord Genuity
Buy
Maintained
40,00 $
+134,6%
11/10/2026
David Larsen
BTIG
Hold
Maintained
-
-
11/09/2026
Glen Santangelo
Barclays
Buy
Maintained
35,00 $
+105,3%
11/10/2026
Jailendra Singh
Truist Financial
Hold
Reiterated
32,00 $
+87,7%
09/11/2026
George Hill
Deutsche Bank
Hold
Reiterated
26,00 $
+52,5%
08/11/2026
Jonna Kim
TD Cowen
Hold
Reiterated
30,00 $
+76%
08/11/2026
Daniel Grosslight
Citi
Hold
Maintained
33,00 $
+93,5%
08/12/2026
Oliver Chen
TD Cowen
Hold
Reiterated
25,00 $
+46,6%
05/12/2026
Cory Carpenter
J.P. Morgan
Buy
Maintained
33,00 $
+93,5%
05/12/2026
Unknown Analyst
Nephron
Buy
Upgraded
35,00 $
+105,3%
03/09/2026
Last report
10 նոյ, 2026 թ.
Fiscal period
Q3 2026
0,03 $ / 0,15 $
-81,97%miss
Revenue / Est. (USD)
890,37 մլն / 892,77 մլն
-0,27%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
2026 թ. սեպ
Revenue
617,82 մլն
608,10 մլն
753,21 մլն
890,37 մլն
Cost of goods sold
173,38 մլն
182,82 մլն
272,41 մլն
381,17 մլն
Cost of revenue
173,38 մլն
182,82 մլն
272,41 մլն
381,17 մլն
Research and development expenses
40,96 մլն
46,94 մլն
54,90 մլն
69,39 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
386,64 մլն
426,37 մլն
521,95 մլն
505,96 մլն
Operating expense
427,60 մլն
473,31 մլն
576,85 մլն
575,34 մլն
Total operating expenses
600,99 մլն
656,13 մլն
849,26 մլն
956,52 մլն
Operating income
16,83 մլն
-48,02 մլն
-96,04 մլն
-66,15 մլն
Other non operating income
1,82 մլն
-18,58 մլն
-2,43 մլն
-514,00 հզր
EBT including unusual items
18,35 մլն
-101,55 մլն
-92,63 մլն
-46,25 մլն
EBT excluding unusual items
21,56 մլն
-61,57 մլն
-96,22 մլն
-67,36 մլն
Income tax expense
-2,25 մլն
-9,44 մլն
-6,34 մլն
-13,21 մլն
Effective tax rate
-12,25%
9,29%
6,85%
28,56%
Other operating expenses
-
-
-
-
Net income
20,60 մլն
-92,12 մլն
-86,29 մլն
-33,04 մլն
Net profit margin
3,33%
-15,15%
-11,46%
-3,71%
Earnings per share
0,22
-0,19
-0,09
0,03
Interest and investment income
3,83 մլն
7,90 մլն
6,00 մլն
4,80 մլն
Interest expense
-921,00 հզր
-2,87 մլն
-3,75 մլն
-5,50 մլն
Net interest expenses
2,90 մլն
5,03 մլն
2,25 մլն
-702,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
34,92 մլն
-26,07 մլն
-66,57 մլն
-27,94 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google Apps